CNX Therapeutics has acquired the global Sativex (nabiximols) business from Jazz Pharmaceuticals, reinforcing its position in the central nervous system (CNS) therapeutic space. The transaction was ...

CNX Resources Corp (NYSE:CNX) reported significant free cash flow generation, which supported a sizable buyback during the third quarter. The company successfully acquired remaining Utica rights on ...

PITTSBURGH, Oct. 30, 2025 /PRNewswire/ -- CNX Resources Corporation (NYSE: CNX) ("CNX" or "the company") today released financial and operational results for the third quarter of 2025 by posting those ...

PITTSBURGH - On Thursday, CNX Resources Corporation (NYSE:CNX) reported third quarter earnings that significantly exceeded analyst expectations, with both revenue and earnings per share coming in well ...

CNX's heavy hedging limits upside from rising natural gas prices, making it unattractive for bullish gas investors through 2027. Despite aggressive share buybacks and consistent free cash flow, CNX ...

In trading on Friday, shares of CNX Resources Corp (Symbol: CNX) entered into oversold territory, changing hands as low as $28.54 per share. We define oversold territory using the Relative Strength ...

The Marcellus and Utica gas producer reported $432.52 million in net profit for Q2, rebounding from two consecutive quarters of losses. CNX Resources Corp. has reported $432.52 million in net profit, ...

CNX Resources Corporation (NYSE:CNX) Q2 2025 Earnings Call Transcript July 24, 2025 CNX Resources Corporation beats earnings expectations. Reported EPS is $0.597, expectations were $0.39. Operator: ...

July 24 (Reuters) - U.S. energy firm CNX Resources (CNX.N), opens new tab said in its second quarter earnings that it plans to produce more natural gas this year than previously expected to meet ...

President and Chief Executive Officer — Nick DeIuliis Chief Operating Officer — Alan Shepard Chief Operating Officer, Upstream — Navneet Behl Vice President, Investor Relations and Public Relations — ...